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Abstract
NCS-1 is a member of the neuronal calcium sensor (NCS) family of EF-hand Ca
2+ binding proteins which has been implicated
in several physiological functions including regulation of neurotransmitter release, membrane traffic, voltage gated Ca
2+
channels, neuronal development, synaptic plasticity, and learning. NCS-1 binds to the dopamine D2 receptor, potentially
affecting its internalisation and controlling dopamine D2 receptor surface expression. The D2 receptor binds NCS-1via a
short 16-residue cytoplasmic C-terminal tail. We have used NMR and fluorescence spectroscopy to characterise the
interactions between the NCS-1/Ca
2+ and D2 peptide. The data show that NCS-1 binds D2 peptide with a Kd of ,14.3 mM
and stoichiometry of peptide binding to NCS-1 of 2:1. NMR chemical shift mapping confirms that D2 peptide binds to the
large, solvent-exposed hydrophobic groove, on one face of the NCS-1 molecule, with residues affected by the presence of
the peptide spanning both the N and C-terminal portions of the protein. The NMR and mutagenesis data further show that
movement of the C-terminal helix 11 of NCS-1 to fully expose the hydrophobic groove is important for D2 peptide binding.
Molecular docking using restraints derived from the NMR chemical shift data, together with the experimentally-derived
stoichiometry, produced a model of the complex between NCS-1 and the dopamine receptor, in which two molecules of
the receptor are able to simultaneously bind to the NCS-1 monomer.
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Introduction
The neuronal calcium sensor (NCS) proteins are EF-hand
containing Ca
2+- binding proteins that detect Ca
2+ signals to
regulate a wide range of cellular functions in neurons, photore-
ceptor cells and other cell types [1]. The NCS family consists of
proteins encoded by 14 genes in mammalian species and there also
additional splice variants. The family can be divided into five
groups consisting of NCS-1, the neurocalcins/VILIPs (visinin-like
proteins), recoverin, GCAPs (guanylate cyclase activating proteins)
and the KChIPs (K
+ channel interacting proteins) [1]. Despite
there being high levels of sequence similarity between the NCS
proteins, genetic studies have indicated that they have specific
non-overlapping functions that cannot be compensated for by
other family members [2,3]. The specificity of their physiological
roles depends in part on specific interaction with and regulation of
distinct target proteins.
One member of the NCS family, NCS-1, has orthologues from
Saccharomyces cerevisiae (Frq1) [4] to man and has been implicated in
several physiological functions including regulation of neurotrans-
mitter release [5,6], membrane traffic [7], voltage gated Ca
2+
channels [8,9,10], neuronal development [11,12], synaptic
plasticity [13,14] and learning [15,16]. NCS-1 is N-terminally
myristoylated which allows its association with distinct membrane
compartments including the plasma membrane and the trans-
Golgi network [17] and it cycles between membrane-bound and
cytosolic pools [18]. It has been shown to interact with a wide
range of target proteins [19,20] including phosphatidylinositol-4-
kinase (PI4K) IIIb [7,21] and its orthologue Pik1 in yeast [4],
ARF1 [7,22], interleukin receptor accessory protein like-1
(IL1RAPL1)[23], TRPC5 channels [11], InsP(3) receptors [24]
and the dopamine D2 and D3 receptors [25].
The interaction of NCS-1 with the dopamine D2 receptor is
potentially of considerable interest considering the key physiolog-
ical role of dopamine signalling within the CNS and its implication
in addictive behaviour [26]. In addition the D2 receptor subtype is
the target for most antipsychotic drugs [27] and such drugs affect
the expression levels of NCS-1 [28]. The D2 receptor possesses a
short 16 residue intracellular C-terminal domain and in a yeast 2-
hybrid screen this was found to bind to NCS-1. The functional
effect of the NCS-1-D2 interaction was shown to be inhibition of
the phosphorylation and subsequent internalisation of D2 receptors
following ligand binding in a heterologous cell line [25]. More
recently a physiological role for NCS-1 in controlling dopamine D2
receptor surface expression and thereby in modifying synaptic
plasticity and exploratory behaviour has been established in mice [16].
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terminus of the dopamine D2 receptor has been speculated upon
[29] but has not been established through structural investigations.
Structures of several NCS proteins have been determined by use of
X-ray crystallography or NMR spectroscopy including for NCS-1
[30]. In addition, the structures of three complexes of NCS
proteins with fragments of target proteins have been solved. These
are for S. cerevisiae Frq1 with a fragment of Pik1 [31] (and a very
similar complex for the equivalent proteins from Schizosacchar-
omyces pombe [32]), recoverin with an N-terminal fragment of
rhodopsin kinase [33] and KChIP1 with an N-terminal domain of
the Kv4.3 potassium channel [34,35]. In each case the target
peptide was bound within a solvent-exposed hydrophobic cleft in
the Ca
2+-loaded form of the NCS protein. The cleft was formed
from hydrophobic residues conserved in all of the NCS family
members (Figure 1) suggesting that a similar mode of target
binding could be used by all of the NCS proteins although
variation in the size of the exposed cleft and surface area available
for the interaction with different target proteins could contribute to
target specificity.
A large hydrophobic cleft was exposed in Ca
2+-bound NCS-1 in
the crystal structure suggesting that this could be the site of protein
ligand interaction [30]. Surprisingly, however, data from the use of
yeast 2-hybrid screening suggested that the D2 receptor C-
terminus could interact with the extreme N-terminus (residues 1–
71) of NCS-1 when expressed alone. This finding could indicate a
different mode of target interaction to that seen for other NCS
protein-target interactions. In order to determine if this is indeed
the case and whether this interaction could provide a specific
target for drug action, we have set out to further characterise the
interaction of the D2 receptor C-terminus with NCS-1 by use of
fluorescence spectrophotometry and NMR spectroscopy. The data
suggest that D2 peptide interacts with NCS-1 in a 2:1 peptide:
protein stoichiometry, and that the peptide binds to the large
hydrophobic groove on one face of the NCS-1 molecule. The data
further show that movement of the C-terminal helix of NCS-1 to
fully expose the hydrophobic groove may be important for D2
peptide binding.
Materials and Methods
Peptide synthesis
The peptide (hereafter referred to as D2 peptide) used here
corresponds to residues 428–443 of the human D2 receptor. The
synthetic D2 peptide (TFNIEFRKAFLKILHC) and its modified
form D2SR (TFNIEFRKAFLKILHSR), were purchased from
Peptide Protein Research Ltd., Fareham, PO15 6DP, UK. The
shorter form, corresponding to residues 428–435 (TFNIEFRK)
were, purchased from GenicBio, China. The peptides was
delivered .95% pure. Both D2 and D2SR peptides were rather
insoluble in aqueous buffer. DMSO was found to be the most
suitable organic solvent for the initial solubilisation of the peptide.
Therefore, in all the experiments, peptide samples were first
dissolved in a minimal amount of DMSO and then diluted with
the relevant buffer. If necessary, pH values of the samples were re-
adjusted to the desired value.
Plasmid production
An expression construct of Rattus norvegicus NCS-1 [6] was sub-
cloned from a pGEX-6p plasmid expressing NCS-1 [36] into
pET-M11 vector. The primers were designed based on the cDNA
sequence obtained from GenBank accession no. L27421 with
Figure 1. Conserved hydrophobic residues involved in protein target interactions in NCS proteins. The secondary structure elements
indicated are obtained from the crystal structure of human NCS-1 (1G8I). The region between 134–138 is either unstructured or form a short helix; the
latter is indicated in this figure. The residues identified to make contact with target peptides in the recoverin/rhodopsin kinase [33], Frq1/Pik1 [31]
and KChIP1/Kv4 [35] complexes are indicated above the corresponding amino acids in NCS-1 which are all conserved hydrophobic residues. For the
Frq1/Pik1 complex residues are indicated that interact with the two alpha helices of Pik1 n the N- and C-terminal parts of the hydrophobic groove.
doi:10.1371/journal.pone.0027779.g001
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sense strands were 59GGCGCCATGGGGAAATCCAACAG-
CAAGTTG 39 and 59CGGATCCGGTACCTTA CTA TAC
CAG CCC GTC GTA 3 9 respectively. Polymerase chain reaction
was carried out using KOD Hot Start DNA Polymerase from
Novagen. Confirmation of the insert was obtained through DNA
sequencing. The R102Q mutation [18] was generated by site-
directed mutagenesis.
Protein expression and purification
NCS-1 plasmid was transformed into E.coli strain BL21 (DE3)
(Novagen). Protein expression in Luria Broth (LB) and 2M9
minimal media performed by growing the cells to mid log (0.6–0.7
OD A
o600) at 30
uC; after induction with 1 mM IPTG the culture
was left to grow overnight at 18
uC.
15N NCS-1 and doubly labelled
13C
15N proteins were expressed using 2M9 media containing
15NH4Cl only or
13C glucose and
15NH4Cl as the carbon and
nitrogen source. 1 ml of the starter culture was grown in LB
overnight, centrifuged, and the pellet added to a 50 ml labelled
media and left to grow overnight in 50 ml labelled culture. The
overnight culture was used to inoculate the labelled growth
medium so that the starting optical density was less than 0.1 A-600
and protein expressed as described above. Cells were harvested
and resuspended into the lysis buffer (50 mM TrisHCl, 200 mM
NaCl 5 mMCaCl2 pH 7.5 plus a tablet per litre of culture of
Complete EDTA Free Protease inhibitor (Roche Applied Science).
The cells were lysed using a French Press. Deoxyribonuclease I
(250 mg) from bovine pancreas (Sigma) was added to the cell lysate
and the lysate was centrifuged at 20 K RPM (47,807 g) for
30 mins. The supernatant was collected and filtered through
0.22 m acrodisc and loaded on to the Hiprep 16/10 Phenyl FF
High Sub (GE Healthcare) column that had been pre-equilibrated
with Buffer-A (50 mM TrisHCl, 200 mM NaCl and 5 mM CaCl2
pH 7.5). Unbound proteins were removed through extensive wash
with Buffer A. A second wash with Buffer B (50 mM TrisHCl,
0.5 mM CaCl2 pH 7.5) removed further impurities. NCS-1 was
eluted from the column with MilliQ water. Eluted protein was
buffer exchanged into Tobacco Etch Virus (TEV) protease
cleavage buffer (50 mM Tris 500 mM NaCl pH 7.4) and the N-
terminal his tag cleaved overnight at 4
uC using a 1:20 molar ratio
of TEV protease:NCS-1. The cleaved protein was further purified
using Superdex 75 Hiload 26/60 (Amersham Biosciences) size
exclusion column (50 mM TrisHCl, 150 mM NaCl pH 7.5). The
yield from one litre of culture was between 50–100 mgs. The
purity of the NCS-1 was confirmed by SDS-PAGE. Confirmation
of the identity of the purified NCS-1 was obtained through Maldi-
tof mass spectrometry. Analysis of the protein was carried out
using Size Exclusion Chromatography Multi-angle Laser Light
Scattering (SEC-MALS) which indicated that NCS-1 was
monomeric.
Spectrofluorometry
To monitor intrinsic tryptophan fluorescence of NCS-1 proteins
[36,37], purified recombinant NCS-1 at a concentration of 1 mM
in a calcium free buffer (20 mM HEPES, 139 mM NaCl, 2 mM
ATP, 5 mM EGTA, 5 mM nitrolotriacetic acid, pH 7.4) were
excited at room temperature with 280 nm light, and their emission
spectra from 290–410 nm were measured, using a Jasco FP-6300
spectrofluorometer (Tokyo, Japan). The concentration of free
calcium was increased by addition of CaCl2 to give a calculated
free Ca
2+ concentration of 1 mM and an additional emission
spectrum were measured. The D2 peptide was then added to give
incremental increase in peptide concentration with emission
spectra measured after each addition. The data for the measured
fluorescence change at each peptide concentration were fitted to a
logistic fit using non-linear curve fitting in OriginPro (Microcal).
NMR Spectroscopy
NCS-1 was prepared in Tris buffer pH 6.8 in the presence of
5 mM MgCl2 and 5 mM CaCl2. Unless otherwise state, NMR
spectra were recorded at 27 uC on Bruker DRX 800 and 600 MHz
spectrometers equipped with CryoProbes. Data were processed
using the Bruker Software TopSpin and analysed using CCPN
software [38]. Sequence-specific backbone and side-chain reso-
nance assignment of NCS-1 was transferred from the previously
reported assignments [39] on unmyristoylated Ca
2+ loaded NCS-1
(Biological Magnetic Resonance Data Bank accession number
4378); however, due to differences in sample conditions and
temperature, many resonances were re-assigned during the course
of these studies using HNCA, HN(CO)CA, HNCO, HN(CA)CO,
CBCA(CO)NH, CBCANH, HBHA(CO)NH and HCCH-TOCSY
experiments.Inaddition,theresonanceassignment forthe aromatic
side-chain had been incomplete. The aromatic side-chains were
partially assigned using 2D [
1H,
13C] -TROSY, and homonuclear
TOCSY and NOESY spectra recorded in D2O.
Two peptides D2 and D2SR were used for the NMR studies.
Secondary structure prediction showed that the addition of the
two extra amino acids did not significantly affect the helical
content of the D2 peptide but in theory could increase solubility,
although in practice the solubility improvement was only
marginal. Both peptides had similar effects on the NCS-1 NMR
spectrum. Since D2SR did not have the complications of cysteine
oxidation over prolonged NMR experiments, the data from this
peptide was used for the final analyses. The peptides were first
dissolved in minimal amounts of DMSO (approximately 1–2 ml)
before adding the protein solution to achieve the appropriate
peptide to protein ratio.
The minimum chemical-shift differences between free and D2-
bound NCS-1 were expressed as: Dd=! {(DH/0.03)
2 + (DN/
0.03)
2}. Values of Dd greater than 0.07 were considered significant.
NCS1-D2 and NCS-1-D3 complex modelling
Due to exchange broadening, attempts to obtain Intermolecular
NOEs between
15N
13C labelled NCS-1 and unlabelled peptide
using filtered NOESY experiments [40] were unsuccessful.
Peptide-protein docking utilised the restraints-driven docking
Webserver programme HADDOCK 2.1 (High Ambiguity Driven
biomolecular DOCKing) [41]. For these docking experiments, the
known structures of the human NCS-1 (1G8I) with the coordinates
for the extreme C-terminal removed and coordinates for the C-
terminus peptide TFNIEFRKAFLKILSC of the D3 receptor
(residues residues 385–400 from the crystal structure of the
dopamine D3 receptor (PDB Accession 3PBL) were used. The C-
terminus of D3 differs from the D2 receptor by only the
penultimate amino acid (His in D2 rather that Ser in D3). Active
residues used as the Ambiguous Interaction Restraints (AIR)
included NCS-1 residues whose
15N-
1H and
13C-
1H shifts were
significantly perturbed in the presence of D2SR. The hydrophobic
residues of D2SR which could be involved with NCS-1 binding
were identified through sequence and structural alignment with
Pik 1 [31]. The HADDOCK derived structures satisfied the
restraints provided and the D2/D3 peptide docked into the two
hydrophobic grooves previously identified in [31]. To obtained a
model of the complex with the whole D3 receptor, a similar
approach was employed but using the coordinates from the
receptor rather than only the C-terminal polypeptide. AIR
restraints for NCS-1, based on the chemical shift mapping data,
were similar to those used to obtain the protein-peptide complex.
Interaction of the Dopamine D2 Receptor with NCS-1
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F386 to allow for movement in the C-terminal region (equivalent
to the D2 peptide). The docking results were automatically
analysed by the HADDOCKprogramme to provide the cluster of
structures which were deemed the most likely structures. 200
water-refined structures were calculated and clustered together
according to the ligand interface RMSD. The RMSD cut-off for
clustering was 7.5 Angstrom. Individual clusters were analysed and
the RMSD to lowest energy structure, the buried surface area per
cluster and various energy terms (van der Waals, electrostatics) was
calculated. Where more than one cluster was generated, the
cluster of structures with a combination of the lowest energy and
highest buried surface area was used as the top ranking structures.
Results
Affinity and stoichiometry of D2 peptide binding to NCS-
1
To determine if the binding of the dopamine D2 receptor C-
terminus to NCS-1 could be examined in solution we initially used
a 16 residue synthetic peptide corresponding to human D2 (428–
443) or a modified peptide D2SR designed for increased solubility.
To assay binding we measured the intrinsic tryptophan fluores-
cence of NCS-1. The protein has two tryptophan residues and
changes in their fluorescence occurs due to conformational
changes following Ca
2+-binding [37,42]. D2 peptide addition
resulted in an increase in fluorescence in the presence or absence
of Ca
2+ but there was apparently lower affinity for peptide in
Ca
2+-free conditions. Further analysis was carried out, therefore,
in the presence of 1 mM free Ca
2+. Addition of either the D2 or the
D2SR peptide resulted in an additional increase in fluorescence of
a similar magnitude above that following the addition of 1 mM free
Ca
2+ and allowed titration of the binding of the peptide over a
range of concentrations (Figure 2A). The data for the change in
fluorescence versus concentration was fitted with a logistic fit. In
initial experiments with the D2 peptide the dose-response
indicated half-maximal binding at 14.3 mM with a Hill coefficient
of 2.1. From more detailed analyses with the D2SR peptide the
dose-response was fitted to give half-maximum binding at
30.16+5.97 mM (Figure 2B). The binding curves from the
experiments consistently indicated a Hill coefficient close to 1.5.
Hill coefficients greater than 1 would be consistent with a 2:1
stoichiometry of peptide binding to NCS-1 since NCS-1 itself was
monomeric, as assessed by size exclusion chromatography and
multi-angle light scattering (unpublished data).
A yeast 2-hybrid analysis [25] suggested that the shortest
peptide that could bind NCS-1 corresponded to residues 428–435
(TFNIEFRK) of the receptor. This seems surprising as these are
the cytoplasmic residues in closest proximity to the transmem-
brane domain of the receptor and that in the structure of the
dopamine D3 receptor (PDB accession 3PBL), the first two amino
acids TF form part of penultimate helix VII of the receptor, rather
than the C-terminus helix VIII. Nevertheless we tested the ability
of this shorter peptide to bind to NCS-1 but could find no evidence
for an interaction using both fluorescence and NMR titrations
using up to a 10-fold excess of peptide. Preliminary data also shows
that the peptide NIEFRKAFLKILHS is able to bind NCS-1 with
similar affinity to TFNIEFRKAFLKILHS.
Identification of the D2 peptide binding site by NMR
spectroscopy
NMR
1H-
15N HSQC and
1H-
13C HSQC spectra of
15N,
13C-
labelled NCS-1 were obtained. As described previously [43] the
Ca
2+ -bound form of NCS-1 showed sharper peaks compared to
the apo-NCS-1. To identify the D2-binding surface of NCS-1,
NMR
1H-
15N and 1H-13C HSQC spectra of
15N,
13C-labelled
NCS-1 in the presence of increasing concentrations of D2SR were
obtained at two different temperatures (27
uC and 35
uC). At both
temperatures chemical shift changes and/or broadening of specific
NCS-1 resonances were observed (Figure 3). These perturbations
were selective, suggesting that the NCS-1 remains a monomer
when bound to the peptide.
The assignments of the resonances from the bound form were
obtained by tracking the chemical shift changes over the titration
experiment (Figure 4); many of the resonances showed an
intermediate to fast exchange regime. When resonance perturba-
tions are mapped onto the structure of NCS-1 (using Protein Data
Bank structure 1G8I), the most affected ones are from residues
located either in the hydrophobic ligand-binding crevice or in the
regions linking the helical regions of the EF hands (Figure 5). The
least affected regions of the protein are helices1, 5, 8 and part of 2;
these regions form the periphery of the hydrophobic crevice and
hence are unlikely to be involved with ligand binding. As shown in
Figure 5, resonances of residues from both the N-and C-terminus
hydrophobic binding sites are affected (coloured yellow). With the
Figure 2. Binding of the dopamine D2 receptor C-terminus to
NCS-1 monitored using tryptophan fluorescence. (A) The spectra
represent intrinsic tryptophan fluorescence of NCS-1 before and after
addition 1 mMC a
2+ and after subsequent addition of the D2SR peptide.
(B) Extent of the changes in tryptophan fluorescence following
sequential additions of D2SR peptide to the final concentrations
indicated. The data are shown as mean6SEM (n=5) and were fitted
using a logistic fit by non-linear curve fitting.
doi:10.1371/journal.pone.0027779.g002
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1H
15N HSQC spectra of
15N,
13C NCS-1
(1 mM) in 50 mM Tris buffer, 50 mM NaCl, 5 mM CaCl2, pH 6.5, 300 K on Avance Bruker 800 MHz spectrometer in the absence (black) or in the
presence of D2SR at a final concentration of 5 mM (red). (B) Sections of
1H
15N HSQC spectra of
15N,
13C NCS-1 showing the progression of peaks
throughout the peptide titration (from black to red). Shown are the various characteristics of resonance perturbation ranging from complete line-
broadening to gradual change in chemical shifts or a mixture of shifts and line-broadening. (C)
1H
13C HSQC spectra of
15N,
13C NCS-1 (1 mM) (black) in
the presence of D2SR (final concentration of 5 mM) (red) indicating some of the resolved methyl groups with most significant shift changes.
doi:10.1371/journal.pone.0027779.g003
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tometry, it is highly likely that both regions bind the D2 peptides.
This would be consistent with the observed binding of two helices
from Pik1 to Frq1 [31]. In the present studies, many of the
broadened resonances remained undetectable at 35
uC and even
when a three-fold excess of peptide (measured using a 2:1
stoichiometry of peptide: NCS-1) was present. The severe line-
broadening of both the NCS-1 and peptide resonances precluded
the determination of the structure of NCS-1-D2SR spectrum using
conventional methods.
It is clear from the structure of the complex between Frq1 and
Pik1 peptide that the N-terminal ligand binding site is more
hydrophobic than the C-terminus site and this could affect the
relative affinities of the site for the same ligand. Hence, the most
appropriate model for NCS-1 interactions with the D2 peptide is a
complicated two- site model where the binding sites are not
Figure 4. Histogram of chemical shift changes observed on D2 peptide binding to NCS-1. The shifts of NCS-1 in the presence and absence
of D2 peptide (see Experimental Procedures) are compared and the shift differences expressed as Dd=! {(DH/0.03)
2 +(DN/0.03)
2}.The gaps are from
either proline residues or due to the fact that the resonances for these residues very severely broadened and undetectable at 35
uC; most significantly
broadened residues are those from the C-terminus region (from residues 181) and in the unstructured region between residues 128–131.
doi:10.1371/journal.pone.0027779.g004
Figure 5. NMR-derived D2 binding site on NCS-1. (Left) Cartoon diagram of NCS-1 with residues that show significant changes in chemical
shifts and/or line-widths coloured in yellow. (Right) Molecular surface of NCS-1 in the same orientation as the left-hand figure showing that many of
the residues affected by the presence of D2SR are in or surround the hydrophobic crevice of NCS-1. The structures were created using the program
Pymol (The PyMOL Molecular Graphics System, Version 1.3, Schro ¨dinger, LLC).
doi:10.1371/journal.pone.0027779.g005
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several of the resonances also suggests the possibility of an internal
exchange of the peptide between the two sites.
The pertubations of resonances from residues in the flexible
linker region such as residues 138–145 would be consistent with
conformational changes on peptide binding similar for those seen
between unliganded Frq1 and the protein in the FRQ1/Pik1
complex [31,32,44]. This would suggest that NCS-1 undergoes a
similarconformationchangeonbindingD2peptideasseenforFrq1
and that the ligand- bound NCS-1 has a more open hydrophobic
groove than seen in the crystal structure of unliganded NCS-1 [30].
Confirmation that hydrophobic residues from both the N and
C-terminalligand bindingsitesareinvolvedwithpeptideinteraction
comes from the shift changes observed for the methyl resonances in
the
1H-
13C HSQC spectrum; for example, residues such Ile 80, Ala
88, Leu89, Val 124, and 179 are significantly affected by the
presence of D2 peptide (Figure 3C). On the other hand the methyl
groups of L16, Met155, 156 and Ala154 are not significantly shifted
by the presence of the peptide. These results show that the shift
changes caused by the presence of D2 peptide are selective.
Interestingly, resonances of residues from the C-terminus
residues 180–190 which include residues from the C-terminal helix
(helix 11 in Figure 1,helix J inthe crustalstructure [30]) are severely
broadened throughout the peptide titration to the extent that some
are not detectable at all (Figure 6A) even in the presence of a large
excess of peptide. The resonances from this region were the first
ones to be affected in the course of the peptide titration, with the
line-broadening occurring at sub-stoichiometric concentrations of
D2SR. The data suggest that the C-terminal region becomes
disordered upon peptide binding; this is an indication that the C-
terminal helix J is displaced to allow exposure of the hydrophobic
cleft in order for the peptide to bind. This makes sense since in the
crystal structure of NCS-1 (PDB accession number 1G8I), helix 11
occupies the C-terminal hydrophobic binding groove, effectively
blocking any ligand interaction. Disorder of the C-terminal region
was also observed in the Frq1-Pik1 complex [31].
To test the prediction that movement of the C-terminal region is
important for ligand interactions, we examined binding of D2SR
peptide to the autism-related R102Q mutant form of NCS-1. We
have previously shown that the mutation results in a loss of
resonances from amino acids in the C-terminal helix 11 in the
1H-
15N HSQC spectrum of the of
15N-labelled R102Q NCS-1
protein consistentwithincreased dynamics of this C-terminalregion
[18]. It could be predicted, therefore that the R102Q mutation
should increase the accessibility of the hydrophobic groove in NCS-
1 for D2 peptide binding. A direct comparison of D2SR binding to
wild type and R102Q NCS-1 was carried by monitoring changes in
tryptophan fluorescence in parallel. The fluorescence spectra for
wild type and R102Q NCS-1 were essentially identical and similar
fluorescent changes occurred upon Ca
2+ addition with the proteins
having similar affinities for Ca
2+. Addition of D2SR to either
protein increased the level of tryptophan fluorescence (Figure 6B). A
peptide titration indicated that in each case the data could be fitted
to a curve indicating a Hill coefficient of around 1.5 and that the
R102Q mutation increased the affinity of the protein for D2SR by
2.07-fold (Figure 6B,C). This finding is consistent with the
prediction made above.
Modelling of D2/D3 peptide and D3 receptor binding to
NCS-1
We tested the hypothesis that two D2 peptides would bind to
NCS-1 once it had undergone conformational changes similar to
those seen in the Frq1/PIK1 complex. This was done by docking
residues 385–400 from the crystal structure of the dopamine D3
receptor (PDB 2PBL) onto NCS-1. From the modelled structure
(Figure 7A) it is clearly possible that two D3 peptides could be
accommodated in a conformation where the chemical shift per-
turbations are satisfied. In this structure, the C-terminal cysteines
are located towards the centre of NCS-1, with the first pheny-
lalanine residue not in contact with the protein. This model
concurs with our preliminary finding that the shorter peptide
TFNIEFRK is not able to bind NCS-1. The orientation of the
peptide in the C-terminal hydrophobic site corresponds with that
observed for the Pik1 (residues 156–170) interaction with Frq1
[31], and the way the C-terminus of NCS-1 and Frq-1 occupy this
binding site in the structure of unliganded proteins (PDB accession
1G8I and 1FPW).
NCS-1 has also been shown to bind to the dopamine D3
receptor and to regulate its internalisation [25]; the D3 sequence
differs by only one amino acid from D2. Ultimately, it would be
important to understand how NCS-1 interacts with the intact
receptor. We, therefore, constructed a model of the NCS-1-D3
receptor complex using the AIR derived from the D2SR peptide-
NCS-1 chemical mapping data, and taking into consideration that
many of the hydrophobic residues at the C-terminus of D3
receptor are involved in intramolecular interactions with helix I of
the receptor [45]. HADDOCK docking produced a plausible
model shown in Figure 7B. It is possible to sterically accommodate
two receptors docked onto NCS-1, with the C-terminal region
located in similar regions of NCS-1 as the isolated receptor
peptides. Subtle changes at the junction of helices VIII and VII are
required to achieve this complex structure. In addition, in the N-
terminal hydrophobic groove of NCS-1, the bound receptor is
orientated such that its C-terminal helix is in the opposite direction
to that obtained when the peptide alone is used in the docking,
whereas in the C-terminal groove, the peptide and receptor bind
in similar orientations.
Discussion
The positions of hydrophobic residues that are solvent exposed
and form contacts with target peptides from Frq1, recoverin, and
KChIP1 were mapped onto the NCS-1 sequence revealing the
similarities in residues involved in the three characterised inter-
actions and that these correspond to conserved hydrophobic
amino acids in NCS-1 (Figure 1). The determined structures of the
complexes reveal similarities and differences in the binding
interactions. The N-terminus of rhodopsin kinase interacts through
a single helix in an N-terminal hydrophobic pocket [33] and the C-
terminal part of the hydrophobic pocket is occluded by the
recoverin C-terminal J helix (referred to as helix 11 here, as shown
in Figure 1). Recent evidence suggests that residues of the recoverin
J-helix are directly involved in the interaction with rhodopsin kinase
peptide [46]. In contrast, in the Pik1/Frq1 complex two helices of
Pik1 are bound in each of the N- and C-terminal pockets in Frq1
[31]. The interaction of the Kv4.3 N-terminal domain with the
hydrophobic cleft of KChIP1 [34,35] involves similar N-terminal
residues as seen in recoverin/rhodopsin kinase and Frq1/Pik1
complexes and also some residues part way into the region of the C-
terminal pocket in Frq1 bound by the second helix of Pik1. The
structure of Ca
2+-bound NCS-1 shows the presence of a large
hydrophobicgroove stretchingacrossresidues equivalent to bothN-
and C-terminal pockets in Frq1 and in the crystal structure this
grooveisoccupiedbypolyethyleneglycols[30].Thisstructure could
reflect the structure of NCS-1 as it would be after peptide ligand
bindingbutitis also likelythat peptideligandbindingcould result in
additional structural changes in NCS-1 that were not observed in
the crystal structure.
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dopamine D2 C-terminus with NCS-1 was structurally similar to
that in the Frq1/Pik1 complex. Hydrophobic residues in NCS-1
that could be involved in target protein interactions within an
exposed hydrophobic groove include the two tryptophan residues;
the indole NH NMR resonances were severely broadened when
the D2 peptide was present. In unliganded NCS-1, the C-terminal
region including the helix J (helix 11 in Figure 1) forms one side of
the large hydrophobic groove. When D2 peptide binds, the
conformation of this region was severely perturbed, consistent with
Figure 6. Significant line-broadening in the C-terminal region of NCS-1 and effect of the R102Q mutation on peptide binding. (A)
Section
1H
15N HSQC spectra of
15N,
13C NCS-1 (1 mM) in the absence (black) or in the presence of D2SR (final concentration of 0.5 mM) (red) in 50 mM
Tris buffer, 50 mM NaCl, 5 mM CaCl2, pH 6.5, 300 K on Avance Bruker 800 MHz spectrometer. At these initial stages of peptide titration, specific line-
broadening of many residues from the C-terminal region was observed. (B) Extent of the changes in tryptophan fluorescence following sequential
additions of D2SR peptide to the final concentrations indicated in the presence of 1 mMC a
2+. The data were fitted using a logistic fit by non-linear
curve fitting. (C) Curve fitting of data from separate tryptophan fluorescence experiments enables determination of the concentration of D2SR
peptide required for half-maximal binding and the Hill coefficient for wild type and R102Q NCS-1. The data are shown as mean6SEM from 5 (wild
type) or 4 (R102Q) experiments and were compared using an unpaired Student’s t-test.
doi:10.1371/journal.pone.0027779.g006
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for the KChIP1/Kv4.3 complex. In the Frq1/Pik1 complex helix
J was found to be unstructured [31]. In the KChIP1/Kv4.3
structure the C-terminal helix J was found to have undergone a
large conformational change compared to KChIP1 to create the
binding site [35]. The structure of KChIP1 in the complex was
comparable to NCS-1 in the crystal structure where helix J was
displaced by 45
0 compared to the corresponding helix in the un-
liganded neurocalcin structure [47]. The loss of NMR amide
resonances from residues in the J helix (helix 11) suggests that on
D2 peptide binding, this region becomes highly dynamic;
interestingly these resonances were affected when substoichio-
metric amounts of the D2 peptide was present, providing evidence
that movement of helix J is an early event in D2 peptide binding.
In addition, even in recoverin where the significant displacement
of helix J does not occur on ligand binding this helix was found to
be dynamic suggesting transient flickering between states [48]. We,
therefore, suggest a model in which D2 peptide binding to NCS-1
leads to conformational changes including movement of the J helix
to maximally expose the hydrophobic groove. A similar loss in
resonances from residues in the J helix was seen in NCS-1 bearing
an autism-related mutation (R102Q) that was predicted to disrupt
hydrogen binding between helix F and helix J [18]. To test the
idea that movement of the C-terminal helix may be important to
allow D2 peptide binding we compared the binding of the D2RS
peptide to wild-type NCS-1 and the R102Q NCS-1 in which the
C-terminus was already highly dynamic. This demonstrated that
the affinity of binding was increased in the mutant supporting the
model for the behaviour of the C-terminal helix.
Biophysical analysis of NCS-1 was consistent with the protein
being monomeric in the presence or absence of Ca
2+. The data
from spectrophotometry upon D2 peptide binding giving a Hill
coefficient for the binding interaction of greater than 1 would be
consistent with a 2:1 stoichiometry of D2 peptide binding to NCS-
1 suggesting that two molecules of the D2 peptide could bind
within the large hydrophobic groove of NCS-1. The D2 peptide is
predicted to be alpha-helical and the C-terminus of the dopamine
D3 receptor which can also bind to NCS-1 [25] and differs by one
only residue from the D2 peptide forms an amphipathic alpha-
helix in the crystal structure of the D3 receptor [45]. We suggest
that two such alpha-helices could bind within the NCS-1
hydrophobic groove similarly to the two helices from Pik1 that
bind to Frq1 [31]. The NMR resonance shift data are consistent
with conformational changes on D2 peptide binding being similar
to those in the Frq1/Pik1 complex that would allow this. A
HADDOCK model of the NCS-1-peptide complex using
ambiguous interaction restraints derived from the NMR data
could be successfully obtained. These models show that the N-
terminal phenylalanine residue in the peptide is not involved in
NCS-1 binding and this concurs with the binding assays which
showed that the shorter 8-residue peptide (TFNIEFRK) was not
able to bind NCS-1.
Interestingly, Dopamine D2 receptors function in signalling as
homodimers [49,50,51]. This suggests a possible model in which a
single NCS-1 molecule is its Ca
2+ bound state is functionally
associated with both partners of the dimer. We used similar
experimental restraints to drive the docking of two molecules of
the D3 receptor onto NCS-1 which produced a model in which
the C-terminus of the each receptor molecule is located in similar
regions of NCS-1. To accommodate two receptors with minimal
steric clashes, conformational changes around the hinge region
between helices VIII and VII of the receptor are necessary,
together with a change of the orientation of the C-terminal peptide
in the N-terminal hydrophobic groove of NCS-1.
Overall the conclusion from this study are consistent with NCS-
1 fitting a general model for target protein interactions by the NCS
protein family, This would involve binding of one or more alpha-
helices of the target within an exposed hydrophobic domain.
Specificity of interaction with NCS proteins would be determined
by the unique sequences and structurally different dynamics of the
C-terminal helix.
Acknowledgments
The authors wish to acknowledge The University of Liverpool for its
support of the NMR Centre for Structural Biology.
Author Contributions
Conceived and designed the experiments: LPH LYL RDB. Performed the
experiments: HVM LPH LYL PP SRP. Analyzed the data: LPH LYL
RDB. Wrote the paper: LPH LYL RDB.
Figure 7. A proposed model of the complex between NCS-1
and the D2/D3 receptor. (A) Model structure of NCS-1 with C-terminal
peptide TFNIEFRKAFLKILSC.NCS-1 residueswithbackboneand side-chain
chemical shifts that undergo more than 0.07ppm chemical shift changes
or which are completely broadened are coloured yellow. Unaffected NCS-
1 residues are coloured white. The C-terminus D2/D3 peptide (coloured
red) weresimultaneously docked ontoNCS-1 usingHADDOCK 2.1 [41]. (B)
Structure of NCS-1 with the D3 receptor. This structure is superimposed
on the NCS-1-peptide complex described in (a). The receptor is coloured
green with its C-terminus coloured teal. The model shows that it is
possible to dock two receptors into NCS-1, with the C-terminus peptide
placed in similar locations as when using the isolated peptides.
doi:10.1371/journal.pone.0027779.g007
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